Ovarian Cancer Treatment Market To Reach USD 18.3 Billion By 2031. By TMR

Integrating complementary and alternative therapies, psychological support, and nutrition into cancer care can enhance overall patient well being and create opportunities for holistic cancer care centers.Wilmington, Delaware, United States, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global ovarian cancer treatment market was estimated to have acquired US$ 5.1 billion in 2022. It is anticipated to register a 15.4% CAGR from 2023 to 2031 and by 2031, the market is li

Related Keywords

Delaware ,United States ,Canada ,America ,Asia Pacific ,Nikhil Sawlani ,Quest Diagnostics ,Takeda Pharmaceutical Company ,Merck Co Inc ,Roche Holding ,Glaxosmithkline ,Transparency Market Research ,Pfizer Inc ,Transparency Market Research Inc ,Gateway Genomics ,Decode Health ,Key Development ,Cancer Hospitals Centers ,Abbvie Inc ,Bristol Myers Squibb Company ,Market Research ,Ovarian Cancer Treatment Market ,Key Players ,Market Report ,Ovarian Cancer Treatment ,Before Buying ,Breakthrough Therapy Designation ,Myriad Genetics ,Ovarian Cancer Treatment Market Segmentation ,Radiation Therapy ,Hormone Therapy ,Order Copy ,Ovarian Cancer Treatment Market Report ,Canada Toll Free ,Ovarian Cancer ,Global Market ,Clinical Trials ,Wilmington ,Dancer ,Cancer Research ,Research ,